advanced search
DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS
EXPERT VIEW
Kyle Toole
DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS
Kyle Toole, Blair Hutton and James McLusky discuss the value that mathematical modelling can provide in the early stages of injectable drug delivery device development, especially when coupled with appropriate empirical testing in a laboratory setting.
IT’S TIME TO CONSIDER INTRADERMAL DELIVERY
SKIN
Dr Nicky Bertollo
Pharma Latch
IT’S TIME TO CONSIDER INTRADERMAL DELIVERY
Nicky Bertollo, Adam Rock and Saidhbh O’Callaghan discuss the progress Pharma Latch’s intradermal drug delivery platform is making towards realising the potential the intradermal route offers to drug developers, especially for vaccines.
NAVIGATING THE AI REVOLUTION IN THE MEDICAL DEVICES SECTOR: BETWEEN INNOVATION AND REGULATION
EXPERT VIEW
Timothy Bubb
NAVIGATING THE AI REVOLUTION IN THE MEDICAL DEVICES SECTOR: BETWEEN INNOVATION AND REGULATION
Timothy Bubb discusses the potential impact of artificial intelligence and machine learning on the healthcare and drug delivery industries, with an overview of the differing regulatory approaches taken by the EU, US FDA and UK MHRA towards this novel area of digital health.
PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY
SUSTAINABILITY
Philipp Ludihuser
SCHOTT Pharma
PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY
Philipp Ludihuser and Arne Kloke highlight how SCHOTT Pharma’s collaboration with customers and partners in the pharmaceutical industry reduces the carbon emissions from the production of vials, cartridges, ampoules and syringes, as well as introducing circular solutions to increase resource efficiency.
Interview with Bespak’s Louise Righton & Benedicta Bakpa
INTERVIEW
Louise Righton
Bespak
Interview with Bespak’s Louise Righton & Benedicta Bakpa
An increasing global incidence of respiratory diseases, such as asthma and COPD, is driving demand for therapies. Simultaneously, greenhouse gas emissions continue to rise, so the pharma industry must consider how to produce much-needed nasally delivered and orally inhaled medicines whilst minimising environmental impact. Louise Righton and Benedicta Bakpa discuss the many different aspects involved in driving sustainability in inhaled drug delivery – and the next steps.
PRIORITISING SUSTAINABILITY IN PHARMA
SUSTAINABILITY
Jessica Buday
Corning
PRIORITISING SUSTAINABILITY IN PHARMA
Jessica Buday discusses how, in partnership with West Pharmaceutical Services, Corning’s Viridian glass vials are able to simultaneously improve the sustainability and efficiency of pharmaceutical fill-finish lines compared with traditional ISO glass vials, due to their reduced glass volume and proprietary external polymeric coating.
OPPORTUNITY THROUGH INNOVATION – ENVIRONMENTAL AND SOCIAL SUSTAINABILITY IN INJECTION DEVICES
SUSTAINABILITY
John Merhige
Credence MedSystems
OPPORTUNITY THROUGH INNOVATION – ENVIRONMENTAL AND SOCIAL SUSTAINABILITY IN INJECTION DEVICES
John Merhige and Dan Thayer discuss how the successful implementation of ESG principles in the pharmaceutical sector requires innovation that allows sustainability to be seen as an opportunity rather than a burden. Furthermore, the authors present the case that improving on the social aspect of ESG is just as important as improving on the environmental side.
INTERVIEW with GLENN SVEDBERG
INTERVIEW
Glenn Svedberg
Nolato Group
INTERVIEW with GLENN SVEDBERG
Glenn Svedberg engages in a wide-ranging discussion around the role and importance of sustainability in the drug delivery industry, and how Nolato Group has approached implementing this critical aspect of the modern industry landscape. Mr Svedberg considers how sustainability factors play into the relationship between CDMOs like Nolato and pharma companies, the importance of materials and how to drive forward sustainability goals within pharma and drug delivery.
CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY
SUSTAINABILITY
David Pircher
Baumann
CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY
David Pircher provides insights from a sustainability journey, showcasing what suppliers can contribute and how innovation and partnership support a common vision. The article outlines where the industry stands and why sustainability is a top priority, with concrete examples.
FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK
SUSTAINABILITY
Herman Rusch
IGS GeboJagema
FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK
Herman Rusch and Steven van Voorst discuss the steps that IGS GeboJagema has taken to provide its ESG efforts with a robust structure to build on and how doing so has made those efforts more effective and provided the company with clear, meaningful and measurable targets to work towards.
DIVE INTO THE HEART OF PHARMA ”CELEBRATING 35 YEARS OF CPHI”
CONFERENCE SHOWCASE
DIVE INTO THE HEART OF PHARMA ”CELEBRATING 35 YEARS OF CPHI”
Join colleagues from across the industry at CPHI Milan 2024, the premier global event for pharmaceutical professionals, from October 8–10, 2024, at Fiera Milano in Milan, Italy.
SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO
EXPERT VIEW
Will Davies
SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO
Will Davies and Holly Milston consider sustainable pathways towards circularity in the medical device industry.
ENABLING LARGE-VOLUME SUBCUTANEOUS INJECTION WITH A SMART WEARABLE INJECTION PLATFORM
WEARABLES
Dr Leonard Chu
Altek Biotechnology
ENABLING LARGE-VOLUME SUBCUTANEOUS INJECTION WITH A SMART WEARABLE INJECTION PLATFORM
 Leonard Chu presents the Altek Biotechnology's Alby injection platform and highlights its versatility as a delivery platform for large-volume subcutaneous injections.
TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING
WEARABLES
Greg Moakes
LTS
TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING
Greg Moakes and Tzach Sadi the process and benefits of automating the production process for its on-body injector device, Sorrel™.
SYMBIOZE<sup>®</sup>: LARGE-VOLUME ON-BODY INJECTOR PLATFORM FOSTERING PATIENTS’ EXPERIENCE
WEARABLES
Cecile Gross
Nemera
SYMBIOZE®: LARGE-VOLUME ON-BODY INJECTOR PLATFORM FOSTERING PATIENTS’ EXPERIENCE
Cécile Gross and Mark Tunkel discuss the how Nemera's on-body injector platform – Symbioze® – has been developed by drawing on a combination of lessons learned from the history of injection devices and the company’s extensive experience developing drug delivery devices for the parenteral route.
UNLOCKING OPPORTUNITIES IN ON-BODY DELIVERY SYSTEMS THROUGH A PLATFORM TECHNOLOGY APPROACH
WEARABLES
Anna Allegro
Stevanato Group
UNLOCKING OPPORTUNITIES IN ON-BODY DELIVERY SYSTEMS THROUGH A PLATFORM TECHNOLOGY APPROACH
Anna Allegro and Andrea Cuccato discuss how Stevanato’s Vertiva® on-body delivery system exemplifies a platform technology approach to device design, with its 3 and 10 mL formats providing the flexibility necessary to accommodate a wide variety of therapies.
THE IMPORTANCE OF USER-CENTRIC DESIGN WHEN DEVELOPING DEVICES FOR HOME USE
WEARABLES
Simon Bürdel
Gerresheimer
THE IMPORTANCE OF USER-CENTRIC DESIGN WHEN DEVELOPING DEVICES FOR HOME USE
Simon Bürdel and Reza Abedian, discuss the importance and value of conducting human factors studies and user consultations above and beyond regulatory requirements when designing user-centric devices for subcutaneous self-injection in at-home settings.
CCBio’s Quick Dose On-Body Injector
WEARABLES
Jimmy Fan
CC Bio
CCBio’s Quick Dose On-Body Injector
Quick Dose is a reusable on-body injector designed and developed to address the challenges of drug container compatibility and extend the lifecycle. The device aims to provide a more efficient and comfortable drug delivery method for patients and meet evolving market needs.
FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS
WEARABLES
Peter Schmidt
ZwickRoell
FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS
Peter Schmidt details the advantages ZwickRoell’s integrated testing systems offer for ensuring precise and accurate testing of on-body drug delivery systems, including the prevention of static charge and the company’s advanced camera-based measurement systems.
ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY
WEARABLES
Omar Rahman
Enable Injections
ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY
Omar Rahman, Beth Faiman and Lisa Gorski highlight the importance of a comfortable experience for both patients and healthcare providers when it comes to large-volume subcutaneous drug delivery.
TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS
WEARABLES
Dr Andrea Allmendinger
ten23 health
TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS
Andrea Allmendinger, Michael Adler, Carole Delauney and Hanns-Christian Mahler provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.
DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE
EARLY INSIGHT
Dr Chaoyoung Lee
TxSphere
DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE
Chaoyoung Lee and Mike Stout introduce the Horizon wearable micro-pump platform, a cutting-edge advancement in the drug delivery device market that marks a significant contribution to wearable drug-device design.
THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS
EXPERT VIEW
Dave Beckstoffer
THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS
Dave Beckstoffer considers how involving customisation from the outset of an on-body injector development project can not only optimise the patient outcome but also streamline the development timescale for device engineers, with a particular focus on the drive system.
FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN
INDUSTRIALISATION
Lorenzo Vaccarella
Paragon Medical
FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN
Lorenzo Vaccarella highlights six critical areas to consider early in the drug delivery device development journey. He discusses how strategically investing time during the early stages of the design cycle and throughout development can ultimately save both time and cost down the road when the product is being manufactured and deployed into the market.

See what ondrugdelivery's readers and contributors think


Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.


Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.


Matt Kempton user photo
Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.


Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.


Top